Latest Profitability News

Bailador Technology Investments has increased the valuations of its portfolio companies Updoc and PropHero, driving a notable uplift in net tangible assets per share and signaling strong early performance in FY26.

Lefroy Exploration has received a second $0.75 million cash advance from BML Ventures, reinforcing its funding position ahead of key production milestones at the Lucky Strike Gold Project.

Netwealth Group Limited will compensate members affected by the First Guardian Master Fund collapse with $101 million, impacting its 1H26 profit but aiming to restore member confidence swiftly.

Equus Energy Limited launches a $15 million public offer to fund the acquisition and development of the Equus Gas Project in Western Australia, backed by conditional funding from Alcoa. The project boasts a large independently certified contingent gas resource, positioning the company to address looming supply shortfalls in domestic and LNG markets.

Tamawood Limited anticipates a substantial 40% to 50% increase in first-half FY26 profit before tax, driven by a 36.5% rise in sales and improved Work In Progress reporting confirmed by auditors.

Elders Limited has updated its dividend details for the half-year ending September 2025, declaring a fully franked 18 cents per share dividend payable in December, alongside a discounted dividend reinvestment plan.

Commonwealth Bank of Australia announces a fully franked quarterly distribution of AUD 1.1154 per security for its PERLS XIV capital notes, payable in March 2026.

Elsight Limited has landed a substantial US$21.2 million contract for early 2026 deliveries, marking a dramatic increase in forward orders and reinforcing its role in the global defence and uncrewed systems sector.

Treasury Wine Estates moderates its first-half fiscal 2026 outlook due to softer US and China markets, unveiling a major transformation program targeting $100 million in annual cost savings starting next year.

Treasury Wine Estates moderates growth forecasts due to softening demand in key US and China markets, unveiling a major transformation program and cost-saving measures to safeguard brand strength and profitability.

Island Pharmaceuticals has inked a Master Service Agreement with Texas Biomedical Research Institute, enhancing its strategic position to advance Galidesivir through the FDA Animal Rule pathway. This partnership aligns with US government priorities on viral threats and sets the stage for a planned clinical program in early 2026.

Saturn Metals has released a positive Pre-Feasibility Study for its Apollo Hill Gold Project, outlining a 14-year open pit mine with a maiden Ore Reserve of 1.59 million ounces and strong financial returns. The study supports a move to Definitive Feasibility Study with full funding secured through that phase.